tradingkey.logo

Immunoprecise Antibodies Ltd

IPA
2.070USD
0.0000.00%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
95.54MValor de mercado
PerdaP/L TTM

Immunoprecise Antibodies Ltd

2.070
0.0000.00%

Mais detalhes de Immunoprecise Antibodies Ltd Empresa

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

Informações de Immunoprecise Antibodies Ltd

Código da empresaIPA
Nome da EmpresaImmunoprecise Antibodies Ltd
Data de listagemJan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 30
EndereçoIndustrious 823 Congress Ave Suite 300
CidadeAUSTIN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal78701
Telefone16048060626
Sitehttps://www.ipatherapeutics.com/
Código da empresaIPA
Data de listagemJan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.

Executivos da empresa Immunoprecise Antibodies Ltd

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shuji Sato
Dr. Shuji Sato
Vice President - Innovative Solutions
Vice President - Innovative Solutions
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
Por EmpresaUSD
Nome
Receita
Proporção
Project revenue
4.06M
98.40%
Cryo storage revenue
66.00K
1.60%
Product sales revenue
0.00
0.00%
Por RegiãoUSD
Nome
Receita
Proporção
United States of America
2.40M
58.20%
Europe
900.00K
21.82%
Other
550.00K
13.34%
Australia
226.00K
5.48%
Canada
48.00K
1.16%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Project revenue
4.06M
98.40%
Cryo storage revenue
66.00K
1.60%
Product sales revenue
0.00
0.00%

Distribuição de ações

Atualizado em: sáb, 7 de fev
Atualizado em: sáb, 7 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Charmquark TWEE
7.83%
Ingalls & Snyder LLC (Asset Management)
5.78%
Susquehanna International Group, LLP
1.07%
Bath (Jennifer Lynne)
1.07%
Renaissance Technologies LLC
0.47%
Outro
83.77%
Investidores
Investidores
Proporção
Charmquark TWEE
7.83%
Ingalls & Snyder LLC (Asset Management)
5.78%
Susquehanna International Group, LLP
1.07%
Bath (Jennifer Lynne)
1.07%
Renaissance Technologies LLC
0.47%
Outro
83.77%
Tipos de investidores
Investidores
Proporção
Corporation
7.83%
Investment Advisor/Hedge Fund
6.31%
Investment Advisor
1.38%
Individual Investor
1.21%
Hedge Fund
0.71%
Research Firm
0.18%
Venture Capital
0.08%
Bank and Trust
0.07%
Outro
82.24%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
48
4.08M
8.74%
-217.78K
2025Q3
41
3.90M
8.45%
-302.90K
2025Q2
46
8.16M
23.11%
+1.40M
2025Q1
45
6.32M
13.81%
+742.61K
2024Q4
45
4.34M
9.53%
-1.30M
2024Q3
46
5.39M
19.68%
+72.87K
2024Q2
48
5.12M
19.96%
-156.62K
2024Q1
50
5.14M
20.20%
-196.19K
2023Q4
58
5.33M
20.96%
+124.72K
2023Q3
50
4.91M
19.67%
-438.42K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Charmquark TWEE
3.66M
7.83%
--
--
Jul 25, 2025
Ingalls & Snyder LLC (Asset Management)
2.70M
5.78%
-79.67K
-2.87%
Sep 30, 2025
Susquehanna International Group, LLP
501.70K
1.07%
-197.54K
-28.25%
Sep 30, 2025
Bath (Jennifer Lynne)
498.12K
1.07%
--
--
Aug 27, 2025
Renaissance Technologies LLC
220.48K
0.47%
+180.00K
+444.66%
Sep 30, 2025
Marshall Wace LLP
168.65K
0.36%
+168.65K
--
Sep 30, 2025
Two Sigma Investments, LP
108.93K
0.23%
+18.08K
+19.90%
Sep 30, 2025
Allianz Global Investors Asia Pacific Limited
60.00K
0.13%
+60.00K
--
Sep 30, 2025
Morgan Stanley Smith Barney LLC
55.00K
0.12%
+45.00K
+450.00%
Sep 30, 2025
XTX Markets LLC
37.39K
0.08%
-53.99K
-59.08%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI